Ken Griffin Tela Bio, Inc. Transaction History

Citadel Advisors LLC

$559 Billion
Q4 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Tela Bio, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 3,700 shares of TELA stock, worth $8,399. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,700

Previous 8,900 58.43%

Holding current value

$8,399

Previous $22,000 50.0%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$2.38 - $3.14 $100,312 - $132,344	42,148 Added 293.47%	56,510 $170,000
Q3 2024 Nov 14, 2024	SELL	$2.32 - $5.04 $406,791 - $883,718	-175,341 Reduced 92.43%	14,362 $36,000
Q2 2024 Aug 14, 2024	BUY	$4.39 - $6.36 $775,734 - $1.12 Million	176,705 Added 1359.48%	189,703 $891,000
Q1 2024 May 15, 2024	BUY	$5.3 - $7.61 $68,889 - $98,914	12,998 New	12,998 $73,000
Q3 2023 Nov 14, 2023	BUY	$7.85 - $10.68 $227,092 - $308,961	28,929 Added 464.35%	35,159 $281,000
Q2 2023 Aug 14, 2023	SELL	$9.23 - $11.23 $247,788 - $301,480	-26,846 Reduced 81.16%	6,230 $63,000
Q1 2023 May 15, 2023	BUY	$9.41 - $12.03 $191,719 - $245,099	20,374 Added 160.4%	33,076 $351,000
Q4 2022 Feb 14, 2023	BUY	$6.5 - $11.5 $82,563 - $146,073	12,702 New	12,702 $146,000
Q3 2020 Nov 16, 2020	SELL	$11.64 - $16.86 $726,592 - $1.05 Million	-62,422 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.75 - $22.61 $375,479 - $1.1 Million	48,449 Added 346.73%	62,422 $809,000
Q1 2020 May 15, 2020	BUY	$5.39 - $18.33 $75,314 - $256,125	13,973 New	13,973 $109,000

Others Institutions Holding TELA

# of Institutions

Shares Held

27.4M

Call Options Held

754K

Put Options Held

300

View Full List

About TELA Bio, Inc.

Ticker TELA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,157,600
Market Cap $43.5M
Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...

More about TELA

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account